Maxcyte, INC. (MXCT) — 8-K Filings

All 8-K filings from Maxcyte, INC.. Browse 18 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (18)

8-K Filing — Nov 12, 2025
MaxCyte, Inc. Files 8-K on Financials — Nov 5, 2025 Risk: low
MaxCyte, Inc. filed an 8-K on November 5, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements an
MaxCyte Files 8-K on Exit Costs and Disclosures — Sep 22, 2025 Risk: medium
MaxCyte, Inc. filed an 8-K on September 22, 2025, reporting on cost associated with exit or disposal activities, Regulation FD disclosure, and financial stateme
MaxCyte, Inc. Reports Leadership Changes and Compensation Details — Aug 11, 2025 Risk: medium
MaxCyte, Inc. filed an 8-K on August 11, 2025, reporting on the departure of directors or certain officers, the election of directors, and the appointment of ce
MaxCyte, Inc. Files 8-K Report — Jun 25, 2025 Risk: low
On June 25, 2025, MaxCyte, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or
MaxCyte Licenses Flow Electroporation Tech to Pharma Giant — Jun 18, 2025 Risk: medium
MaxCyte, Inc. announced on June 18, 2025, that it has entered into a collaboration and license agreement with a leading global pharmaceutical company. This agre
MaxCyte Files 8-K on Operations and Financials — May 7, 2025 Risk: low
MaxCyte, Inc. filed an 8-K on May 7, 2025, reporting on its results of operations and financial condition. The filing also includes Regulation FD disclosures an
MaxCyte, Inc. Files 8-K for Financials and Reg FD — Jan 30, 2025 Risk: low
MaxCyte, Inc. filed an 8-K on January 30, 2025, to report on financial statements and exhibits, as well as a Regulation FD disclosure. The filing does not conta
MaxCyte, Inc. Files 8-K on Financials — Jan 13, 2025 Risk: low
MaxCyte, Inc. filed an 8-K on January 13, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements an
MaxCyte Appoints New Chief Medical Officer — Dec 27, 2024 Risk: low
MaxCyte, Inc. announced on December 22, 2024, the appointment of Dr. David L. Davenport as Chief Medical Officer. Dr. Davenport brings extensive experience in c
MaxCyte, Inc. Files 8-K on Exit Costs — Dec 9, 2024 Risk: medium
On December 4, 2024, MaxCyte, Inc. filed an 8-K report detailing cost associated with exit or disposal activities. The filing also includes Regulation FD Disclo
MaxCyte, Inc. Files 8-K on Financials — Nov 6, 2024 Risk: low
MaxCyte, Inc. filed an 8-K on November 6, 2024, reporting on its results of operations and financial condition. The filing also includes Regulation FD disclosur
MaxCyte Appoints New Chief Medical Officer — Oct 15, 2024 Risk: medium
MaxCyte, Inc. announced on October 14, 2024, the appointment of Dr. Aris D. T. K. K. Patel as Chief Medical Officer. Dr. Patel brings extensive experience in cl
MaxCyte Elects New Directors, Stockholder Proposals Approved — Jun 12, 2024 Risk: low
MaxCyte, Inc. announced on June 11, 2024, the election of Dr. David L. Brown and Ms. Jennifer L. D. Sim as Class II directors to its Board of Directors, effecti
MaxCyte, Inc. Files 8-K on Financials — May 7, 2024 Risk: low
MaxCyte, Inc. filed an 8-K on May 7, 2024, reporting on its results of operations and financial condition. The filing also includes Regulation FD disclosures an
MaxCyte Files 8-K on Operations and Financials — Mar 5, 2024 Risk: low
MaxCyte, Inc. filed an 8-K on March 5, 2024, reporting on its results of operations and financial condition as of March 4, 2024. The filing includes financial s
MAXCYTE 8-K: Officer/Director Changes & Comp Arrangements — Jan 26, 2024
MAXCYTE, INC. filed an 8-K on January 26, 2024, reporting an event that occurred on January 23, 2024, related to changes in directors or officers and their comp
MAXCYTE Files 8-K on Financial Condition & Operations — Jan 8, 2024
MAXCYTE, INC. filed an 8-K on January 8, 2024, to report on 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits'. This filing

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX